Evolving capabilities of computed tomography imaging for transcatheter valvular heart interventions – new opportunities for precision medicine.
September 30, 2024Recent advancements in MDCT enhance precision in heart valve interventions. π« This review highlights innovative imaging techniques for improved patient care. π
A Deep Learning Method for Human Sleeping Pose Estimation with Millimeter Wave Radar.
September 30, 2024A recent study highlights a deep learning approach using radar for sleep posture recognition. Promising results show 82.74% accuracy. π€π
eHealth Assistant AI Chatbot Using a Large Language Model to Provide Personalized Answers through Secure Decentralized Communication.
September 30, 2024AI chatbots enhance patient care by providing personalized medical information securely. π€π¬ Review of PubMed article highlights innovative eHealth solutions.
Birth of Industry 5.0: Making Sense of Big Data with Artificial Intelligence, “The Internet of Things” and Next-Generation Technology Policy.
September 30, 2024Exploring Industry 5.0: AI, IoT, and Big Data's impact on health and technology. π€π Safety and innovation are key.
AI Governance: A Challenge for Public Health.
September 30, 2024AI governance poses challenges for public health. π₯ Balancing benefits and risks is crucial for equitable outcomes. π€
Decoding Missense Variants by Incorporating Phase Separation via Machine Learning.
September 30, 2024Recent research highlights a machine learning model, PSMutPred, predicting missense variant impacts on phase separation. π§¬π
Imaging colonic polyps in 2024.
September 30, 2024Colonoscopy is vital for colorectal cancer prevention. Recent advances in imaging techniques enhance polyp detection and management. π©Ίπ
[Progress in application of machine learning in epidemiology].
September 30, 2024Machine learning is transforming epidemiology, enhancing disease diagnosis and risk prediction. We reviewed a PubMed article on this progress. ππ€
Machine learning and biological validation identify sphingolipids as potential mediators of paclitaxel-induced neuropathy in cancer patients.
September 30, 2024Recent research highlights sphingolipids, particularly sphinganine-1-phosphate, as key players in paclitaxel-induced neuropathy. π§ π